Nishino, Masami https://orcid.org/0000-0003-0309-7023
Egami, Yasuyuki
Sugino, Ayako
Kobayashi, Noriyuki
Abe, Masaru
Ohsuga, Mizuki
Nohara, Hiroaki
Kawanami, Shodai
Ukita, Kohei
Kawamura, Akito
Yasumoto, Koji
Okamoto, Naotaka
Matsunaga-Lee, Yasuharu
Yano, Masamichi
Yamada, Takahisa
Yasumura, Yoshio
Seo, Masahiro
Hayashi, Takaharu
Nakagawa, Akito
Nakagawa, Yusuke
Tamaki, Shunsuke
Okada, Katsuki
Sotomi, Yohei
Nakatani, Daisaku
Hikoso, Shungo
Sakata, Yasushi
,
Article History
Received: 9 January 2025
Accepted: 2 April 2025
First Online: 15 April 2025
Change Date: 9 May 2025
Change Type: Update
Change Details: The original online version of this article was revised: the copyright holder name was corrected to The Author(s), under exclusive licence to Sakakibara Heart Foundation.
Change Date: 20 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00380-025-02556-0
Declarations
:
: Yohei Sotomi has received grants from Abbott Medical Japan, Biosense Webster, Boston Scientific Japan, Bristol-Myers Squibb, FUJIFILM Toyama Chemical, Roche Diagnostics, TERUMO, TOA EIYO, and NIPRO, and personal fees from Abbott Medical Japan, Amgen Astellas BioPharma, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific Japan, Bristole-Myers Squibb, Daiichi Sankyo, Novartis, TERUMO, Eli Lilly and Company, ONO PHARMACEUTICAL, and Pfizer Pharmaceuticals. Daisaku Nakatani has received honoraria from Roche Diagnostics. Shungo Hikoso has received personal fees from Daiichi Sankyo Company, Bayer, Astellas Pharma, Pfizer Pharmaceuticals and Boehringer Ingelheim Japan, and grants from Roche Diagnostics, FUJIFILM Toyama Chemical and Actelion Pharmaceuticals. Yasushi Sakata has received personal fees from Otsuka Pharmaceutical, Ono Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation and Actelion Pharmaceuticals, and grants from Roche Diagnostic, FUJIFILM Toyama Chemical, Abbott Medical Japan, Otsuka Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma Corporation and Biotronik. The other authors have no conflicts of interest to disclose.